Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3071% below fair value
$3.73−0.13 (-3.37%)
Close on Nov 13, 2026Market cap $70.11MP/E –Yield –
Outset Medical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Outset Medical's price to sales ratio was 0.7× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 23.6×, with a median of 2.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | +0.1 |
| 2025 | Dec 31, 2025 | 0.6× | +0.0 |
| 2024 | Dec 31, 2024 | 0.5× | −1.5 |
| 2023 | Dec 29, 2023 | 2.1× | −9.1 |
| 2022 | Dec 30, 2022 | 11.2× | −12.5 |
| 2021 | Dec 31, 2021 | 23.6× | −37.4 |
| 2020 | Dec 31, 2020 | 61.0× | – |
See a number that looks wrong?